Cash Flow Laboratorios Farmaceúticos Rovi SA Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
183.00
177.00
220.00
257.00
182.00
72.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-12.00
-24.00
-92.00
0.00
-29.00
-40.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
185.00
136.00
114.00
237.00
149.00
46.00
Cash Flow from Investing Activities
-67.00
-75.00
-53.00
-57.00
-40.00
-39.00
Cash Flow from Financing Activities
-47.00
-58.00
-160.00
-154.00
-62.00
-21.00
Net Cash Inflow / Outflow
70.00
1.00
-99.00
25.00
45.00
-14.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Laboratorios Farmaceúticos Rovi SA
Figures in Million
consolidated Cash Flow Results
Change(EUR)
Change(%)
Profit Before Tax
183.203
623
-440.00
-70.59%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-12.752
-25
13.00
48.99%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
185.372
1047
-862.00
-82.29%
Cash Flow from Investing Activities
-67.561
-579
512.00
88.33%
Cash Flow from Financing Activities
-47.021
-529
482.00
91.11%
Net Cash Inflow / Outflow
70.79
-155
225.00
145.67%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-94
94.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 35.66% vs 19.50% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
185.37
136.64
35.66%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
